Viewray (VRAYQ)
OTHER OTC:VRAYQ
VRAYQ Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $4.96
Previous CloseN/A
Volume41.00
Average Volume (3M)N/A
Market Cap
$183.00
Enterprise Value-$45.00M
Total Cash (Recent Filing)$81.29M
Total Debt (Recent Filing)$85.13M
Price to Earnings (P/E)―
Beta9.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding183,402,040
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap-245.89K
Enterprise Value/Revenue-0.43
Enterprise Value/Gross Profit-5.28
Enterprise Value/Ebitda0.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VRAYQ FAQ
What was Viewray’s price range in the past 12 months?
Viewray lowest stock price was <$0.01 and its highest was $4.96 in the past 12 months.
What is Viewray’s market cap?
Viewray’s market cap is $183.00.
When is Viewray’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Viewray’s earnings last quarter?
Currently, no data Available
Is Viewray overvalued?
According to Wall Street analysts Viewray’s price is currently Overvalued.
Does Viewray pay dividends?
Viewray does not currently pay dividends.
What is Viewray’s EPS estimate?
Viewray’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Viewray have?
Viewray has 183,402,040 shares outstanding.
What happened to Viewray’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Viewray?
Currently, no hedge funds are holding shares in VRAYQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Viewray
Established in Denver, Colorado, in 2004, ViewRay, Inc. specialized in the creation, production, and international marketing of magnetic resonance imaging (MRI)-guided radiation therapy systems. These innovative systems were designed to facilitate the precise imaging and treatment of cancer patients across various global markets, including the United States, Italy, France, Taiwan, and the United Kingdom. The company's key offering, MRIdian, was an MRI-guided radiation therapy solution developed to address common issues such as beam distortion and skin toxicity during treatment. ViewRay distributed its products to a broad range of healthcare providers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and dedicated cancer centers, utilizing both its own sales force and a network of distributors. However, ViewRay, Inc. initiated a voluntary Chapter 11 bankruptcy reorganization on July 16, 2023, in the U.S. Bankruptcy Court for the District of Delaware, which was subsequently converted to a Chapter 7 liquidation on October 26, 2023.
Ownership Overview
―
Insiders
1.01% Mutual Funds
<0.01% Other Institutional Investors
98.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---